Brief: Moberg Pharma Decides On A Fully Guaranteed Rights Issue Of About SEK 121 Million

Moberg Pharma AB (publ)

08/04/2022 07:07

April 8 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * MOBERG PHARMA DECIDES ON A FULLY GUARANTEED RIGHTS ISSUE
OF
APPROXIMATELY SEK 121 MILLION
    * SUBSCRIPTION PRICE IS SEK 2.30 PER NEW ORDINARY SHARE.
    * RIGHTS ISSUE COMPRISES ORDINARY SHARES AND WILL PROVIDE
MOBERG
PHARMA WITH PROCEEDS OF APPROXIMATELY SEK 121 MILLION BEFORE
TRANSACTION COSTS.
    * INTENDS TO USE NET PROCEEDS TO FINANCE REGISTRATION
ACTIVITIES
AND CLINICAL WORK FOR MOB-015 AS WELL AS PREPARATIONS FOR LAUNCH
IN EUROPE IN 2023.
    * 13 MAY 2022 - 27 MAY 2022 SUBSCRIPTION PERIOD

Source text for Eikon:  ID:nWkr98y453 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))